Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 1, 2026 · Other material event · Financial statements
Spyre Therapeutics, Inc.
7
Other material event
Jun 1, 2026
| ItemItem | Disclosure |
|---|---|
| Item 8.01 | Other events the company considers material |
| Item 9.01 | Financial statements and exhibits |
Spyre Therapeutics, Inc. filed this to release information to investors under Regulation FD — usually a press release, conference presentation, or other event the company considers important. ) 221 Crescent Street Building 23 Suite 105 Waltham , MA 02453 (Address of Principal Executive Offices) (Zip Code) Registrant’s Telephone Number, Including Area Code: 617 651-5940 Not Applicable (Former Name or Former Address, if Changed Since Last Report) _______________________________________________________ Check the appropriate box below if the Form 8-K…
This filing reports Item 8.01 (other events the company considers material). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Spyre Therapeutics, Inc. reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
